Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (April 2024)
Article in Journal of Clinical Investigation (January 2024)
Article in Scientific Reports (January 2024)